{"id":55136,"date":"2023-03-23T14:04:17","date_gmt":"2023-03-23T13:04:17","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\/"},"modified":"2023-03-23T14:04:17","modified_gmt":"2023-03-23T13:04:17","slug":"abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\/","title":{"rendered":"Abacus Insights Earns HITRUST Risk-Based, 2-Year Recertification of Its Data Transformation Platform"},"content":{"rendered":"
\n

\nMeets the highest standards for cybersecurity, data protection, and risk mitigation <\/i>for health plan clients<\/i><\/b>\n<\/p>\n

BOSTON–(BUSINESS WIRE)–Abacus Insights<\/a>, the leader in data usability for healthcare payers, has earned the HITRUST r2 certification for its Data Transformation Platform hosted at Amazon Web Services (AWS) and Active Directory hosted at Microsoft Azure. For the recertification, Abacus Insights demonstrated that it met the gold standard for regulatory compliance, industry requirements and risk management.\n<\/p>\n

<\/a><\/p>\n

\nThe HITRUST risk-based, two-year (r2) assessment demonstrates expanded practices inclusive of unique risk factors, compliance factors, and a more comprehensive approach to evaluation including policies, processes, and implementation. This achievement places Abacus Insights in an elite group of organizations worldwide that have earned the HITRUST r2 certification.\n<\/p>\n

\n\u201cProtecting the personal information and data security of our payer clients is essential, and it is why we build stringent safeguards into every aspect of our platform, data solutions and overall business,\u201d said Bill Brown, Chief Information Officer and Chief Information Security Officer for Abacus Insights. \u201cBy regularly upgrading our approach and pursuing the most rigorous certifications, we commit to using the most advanced standards, protocols and processes.\u201d\n<\/p>\n

\nWith the only data transformation platform and data solutions developed specifically for health plans, Abacus Insights makes healthcare data usable by ensuring it meets six dimensions\u2014accurate, complete, timely, relevant, versatile and use case and application agnostic. The unmatched control and flexibility of interoperable usable data enables payers to more effectively run and improve operations and analytics and to innovate. Abacus Insights manages data for more than 21 million members.\n<\/p>\n

\n\u201cThe HITRUST Assurance Program is rigorous and reliable because of the comprehensiveness of control requirements, depth of review, and consistency of oversight,\u201d said Bimal Sheth, Executive Vice President, Standards Development & Assurance Operations, HITRUST. \u201cHITRUST Risk-based, 2-year (r2) Certification demonstrates Abacus Insights is taking the most proactive approach to cybersecurity, data protection, and risk management.\u201d\n<\/p>\n

\nIn addition to HITRUST r2 certification, Abacus Insights is SOC2 certified, NIST Cybersecurity Framework and HL7 FHIR compliant and certified a Qualified Entity by the Centers for Medicare and Medicaid Services.\n<\/p>\n

\nAbout Abacus Insights<\/b>\n<\/p>\n

\nAbacus Insights<\/a> is a healthcare technology leader with the only data transformation platform and solutions built specifically for health plans. By setting the new standard of payer data to usability, Abacus Insights gives payers a new level of control and flexibility to support analytics and operational use cases. Managing data for 21 million members, Abacus Insights partners with payers to deliver scalable solutions that drive strategic initiatives, control costs, and improve member lives and experiences.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact:
\n
Lois Padovani
\n
padovanilois@hipposhealth.com<\/a>
773.501.8744\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Meets the highest standards for cybersecurity, data protection, and risk mitigation for health plan clients BOSTON–(BUSINESS WIRE)–Abacus Insights, the leader in data usability for healthcare payers, has earned the HITRUST r2 certification for its Data Transformation Platform hosted at Amazon Web Services (AWS) and Active Directory hosted at Microsoft Azure. For the recertification, Abacus Insights … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55136","6":"format-standard","7":"category-industry"},"yoast_head":"\nAbacus Insights Earns HITRUST Risk-Based, 2-Year Recertification of Its Data Transformation Platform - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abacus Insights Earns HITRUST Risk-Based, 2-Year Recertification of Its Data Transformation Platform - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Meets the highest standards for cybersecurity, data protection, and risk mitigation for health plan clients BOSTON–(BUSINESS WIRE)–Abacus Insights, the leader in data usability for healthcare payers, has earned the HITRUST r2 certification for its Data Transformation Platform hosted at Amazon Web Services (AWS) and Active Directory hosted at Microsoft Azure. For the recertification, Abacus Insights ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-23T13:04:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230323005218\/en\/1745593\/21\/Full_Logo_-_Color.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Abacus Insights Earns HITRUST Risk-Based, 2-Year Recertification of Its Data Transformation Platform\",\"datePublished\":\"2023-03-23T13:04:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\\\/\"},\"wordCount\":439,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230323005218\\\/en\\\/1745593\\\/21\\\/Full_Logo_-_Color.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\\\/\",\"name\":\"Abacus Insights Earns HITRUST Risk-Based, 2-Year Recertification of Its Data Transformation Platform - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230323005218\\\/en\\\/1745593\\\/21\\\/Full_Logo_-_Color.jpg\",\"datePublished\":\"2023-03-23T13:04:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230323005218\\\/en\\\/1745593\\\/21\\\/Full_Logo_-_Color.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230323005218\\\/en\\\/1745593\\\/21\\\/Full_Logo_-_Color.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Abacus Insights Earns HITRUST Risk-Based, 2-Year Recertification of Its Data Transformation Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Abacus Insights Earns HITRUST Risk-Based, 2-Year Recertification of Its Data Transformation Platform - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\/","og_locale":"en_US","og_type":"article","og_title":"Abacus Insights Earns HITRUST Risk-Based, 2-Year Recertification of Its Data Transformation Platform - Pharma Trend","og_description":"Meets the highest standards for cybersecurity, data protection, and risk mitigation for health plan clients BOSTON–(BUSINESS WIRE)–Abacus Insights, the leader in data usability for healthcare payers, has earned the HITRUST r2 certification for its Data Transformation Platform hosted at Amazon Web Services (AWS) and Active Directory hosted at Microsoft Azure. For the recertification, Abacus Insights ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-23T13:04:17+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230323005218\/en\/1745593\/21\/Full_Logo_-_Color.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Abacus Insights Earns HITRUST Risk-Based, 2-Year Recertification of Its Data Transformation Platform","datePublished":"2023-03-23T13:04:17+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\/"},"wordCount":439,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230323005218\/en\/1745593\/21\/Full_Logo_-_Color.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\/","url":"https:\/\/pharma-trend.com\/en\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\/","name":"Abacus Insights Earns HITRUST Risk-Based, 2-Year Recertification of Its Data Transformation Platform - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230323005218\/en\/1745593\/21\/Full_Logo_-_Color.jpg","datePublished":"2023-03-23T13:04:17+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230323005218\/en\/1745593\/21\/Full_Logo_-_Color.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230323005218\/en\/1745593\/21\/Full_Logo_-_Color.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/abacus-insights-earns-hitrust-risk-based-2-year-recertification-of-its-data-transformation-platform\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Abacus Insights Earns HITRUST Risk-Based, 2-Year Recertification of Its Data Transformation Platform"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55136","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55136"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55136\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55136"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55136"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55136"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}